Thursday, May 14, 2009

Novel Therapy May Prove Effective In Treatment Of 30 Percent Of Cancers

ScienceDaily (May 14, 2009) — A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients.

Read More

No comments: